Detalhe da pesquisa
1.
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma.
Clin Gastroenterol Hepatol
; 22(1): 72-80.e4, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442316
2.
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
J Hepatol
; 79(2): 576-580, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030400
3.
Implementation of a re-linkage to care strategy in patients with chronic hepatitis C who were lost to follow-up in Latin America.
J Viral Hepat
; 30(1): 56-63, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36197907
4.
Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC.
Ann Hepatol
; 28(4): 101110, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37100385
5.
'Real-life' experience with direct-acting antiviral agents for HCV after kidney transplant.
Ann Hepatol
; 25: 100337, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33684523
6.
Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1-6 in Brazil.
Ann Hepatol
; 20: 100257, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32949786
7.
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries.
Clin Gastroenterol Hepatol
; 18(2): 457-467.e21, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31306800
8.
Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents.
Clin Gastroenterol Hepatol
; 18(11): 2554-2563.e3, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32113892
9.
Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real-world experience from HCV-LALREAN cohort.
J Med Virol
; 92(12): 3545-3555, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32749710
10.
HEPLA: A multicenter study on demographic and disease characteristics of patients with hepatitis C in Latin America.
Ann Hepatol
; 19(2): 161-165, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31718995
11.
B.A.R.C.O.S. (Brazilian Argentine Hepatitis C Collaborative Observational Study): Effectiveness and clinical outcomes of HCV treatment with daclatasvir and sofosbuvir with or without ribavirin.
J Viral Hepat
; 26(10): 1200-1209, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31141239
12.
Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma.
Liver Int
; 39(6): 1033-1043, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636361
13.
Direct antiviral therapy for treatment of hepatitis C: A real-world study from Brazil.
Ann Hepatol
; 18(6): 849-854, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537509
14.
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.
Ann Hepatol
; 17(6): 959-968, 2018 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30600291
15.
Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil.
Ann Hepatol
; 16(5): 727-733, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28809742
16.
A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirin.
Liver Int
; 34(10): 1550-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24329937
17.
Impact of sustained virologic response on glucose parameters among patients with chronic hepatitis C treated with direct-acting antivirals.
Arch Endocrinol Metab
; 68: e220480, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709148
18.
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update.
Lancet Gastroenterol Hepatol
; 9(4): 346-365, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38367629
19.
High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials.
Hepatology
; 56(6): 2039-50, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22706730
20.
Intensified peginterferon α-2a dosing increases sustained virologic response rates in heavy, high viral load hepatitis C genotype 1 patients with high low-density lipoprotein.
J Clin Gastroenterol
; 47(3): 271-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22951527